Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood

The objective of the optimization of pharmacotherapy compliant with the basic rules of clinical pharmacology is its maximum individualization, ensuring paramount effectiveness and security of the patient’s therapy. Thus, multiple factors that are decisive in terms of uniqueness of treatment of the g...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Lukasz Dobrek
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/838a83b98d4f42dbabe419ba6ab7261e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:838a83b98d4f42dbabe419ba6ab7261e
record_format dspace
spelling oai:doaj.org-article:838a83b98d4f42dbabe419ba6ab7261e2021-11-25T18:41:46ZChronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood10.3390/pharmaceutics131119151999-4923https://doaj.org/article/838a83b98d4f42dbabe419ba6ab7261e2021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1915https://doaj.org/toc/1999-4923The objective of the optimization of pharmacotherapy compliant with the basic rules of clinical pharmacology is its maximum individualization, ensuring paramount effectiveness and security of the patient’s therapy. Thus, multiple factors that are decisive in terms of uniqueness of treatment of the given patient must be taken into consideration, including, but not limited to, the patient’s age, sex, concomitant diseases, special physiological conditions (e.g., pregnancy, lactation, extreme age groups), polypharmacotherapy and polypragmasia (particularly related to increased risk of drug interactions), and patient’s phenotypic response to the administered drug with possible genotyping. Conducting therapy while monitoring the concentration of certain drugs in blood (Therapeutic Drug Monitoring; TDM procedure) is also one of the factors enabling treatment individualization. Furthermore, another material, and yet still a marginalized pharmacotherapeutic factor, is chronopharmacology, which indirectly determines the values of drug concentrations evaluated in the TDM procedure. This paper is a brief overview of chronopharmacology, especially chronopharmacokinetics, and its connection with the clinical interpretation of the meaning of the drug concentrations determined in the TDM procedure.Lukasz DobrekMDPI AGarticlechronopharmacologycircadian rhythmtherapeutic drug monitoringchronopharmacokineticsPharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1915, p 1915 (2021)
institution DOAJ
collection DOAJ
language EN
topic chronopharmacology
circadian rhythm
therapeutic drug monitoring
chronopharmacokinetics
Pharmacy and materia medica
RS1-441
spellingShingle chronopharmacology
circadian rhythm
therapeutic drug monitoring
chronopharmacokinetics
Pharmacy and materia medica
RS1-441
Lukasz Dobrek
Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood
description The objective of the optimization of pharmacotherapy compliant with the basic rules of clinical pharmacology is its maximum individualization, ensuring paramount effectiveness and security of the patient’s therapy. Thus, multiple factors that are decisive in terms of uniqueness of treatment of the given patient must be taken into consideration, including, but not limited to, the patient’s age, sex, concomitant diseases, special physiological conditions (e.g., pregnancy, lactation, extreme age groups), polypharmacotherapy and polypragmasia (particularly related to increased risk of drug interactions), and patient’s phenotypic response to the administered drug with possible genotyping. Conducting therapy while monitoring the concentration of certain drugs in blood (Therapeutic Drug Monitoring; TDM procedure) is also one of the factors enabling treatment individualization. Furthermore, another material, and yet still a marginalized pharmacotherapeutic factor, is chronopharmacology, which indirectly determines the values of drug concentrations evaluated in the TDM procedure. This paper is a brief overview of chronopharmacology, especially chronopharmacokinetics, and its connection with the clinical interpretation of the meaning of the drug concentrations determined in the TDM procedure.
format article
author Lukasz Dobrek
author_facet Lukasz Dobrek
author_sort Lukasz Dobrek
title Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood
title_short Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood
title_full Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood
title_fullStr Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood
title_full_unstemmed Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood
title_sort chronopharmacology in therapeutic drug monitoring—dependencies between the rhythmics of pharmacokinetic processes and drug concentration in blood
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/838a83b98d4f42dbabe419ba6ab7261e
work_keys_str_mv AT lukaszdobrek chronopharmacologyintherapeuticdrugmonitoringdependenciesbetweentherhythmicsofpharmacokineticprocessesanddrugconcentrationinblood
_version_ 1718410783707103232